CS logo
small CS logo
Infusion Associates

Grand Rapids, Michigan, United States
Medical clinic in Grand Rapids Charter Township, Michigan
3230 Eagle Park Dr NE Suite 101, Grand Rapids, MI 49525

About Infusion Associates


"We provide medically-prescribed infusions for patients with chronic disease in a comfortable, friendly environment instead of a sterile, cold hospital."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Chiesi Farmaceutici S.p.A.
3
Amicus Therapeutics
2
Idorsia Pharmaceuticals Ltd.
2
Protalix
2
Bristol-Myers Squibb
1
Eli Lilly and Company
1
Hoffmann-La Roche
1
Horizon Pharma Rheumatology LLC
1
Horizon Therapeutics Ireland DAC
1
Janssen Research & Development, LLC
1
Shionogi
1
Total Rows: 13

Clinical Trials at Infusion Associates


During the past decade, Infusion Associates conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2211444411111100000011000022Started TrialsCompleted Trails20162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Treatment Protocol of Replagal for Patients With Fabry Disease
No longer available
Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic Gout
2011-11-15
2017-06-30
Completed
188
A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
2013-07-31
2017-01-02
Completed
1,081
First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221
2016-01-01
2023-12-01
Active, not recruiting
32
Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function
2016-06-01
2022-07-01
Completed
78
Safety, Efficacy, & PK of PRX-102 in Patients With Fabry Disease Administered Intravenously Every 4 Weeks
2017-07-10
2020-08-01
Completed
30
Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease
2018-06-21
2021-09-02
Completed
182
Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease
2018-09-16
2025-04-01
Active, not recruiting
97

Rows per page:

1–18 of 18

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Infusion Associates" #1 sponsor was "Chiesi Farmaceutici S.p.A." with 3 trials, followed by "Amicus Therapeutics" with 2 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored, "Protalix" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Infusion Associates" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "Chiesi USA, Inc." with 1 trials as a collaborator, "International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsChiesi Farmaceutici S.p.A.: 3Chiesi Farmaceutici S.p.A.: 3Amicus Therapeutics: 2Amicus Therapeutics: 2Idorsia Pharmaceuticals Ltd.: 2Idorsia Pharmaceuticals Ltd.: 2Protalix: 2Protalix: 2Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1Horizon PharmaRheumatology LLC: 1Horizon PharmaRheumatology LLC: 1Horizon TherapeuticsIreland DAC: 1Horizon TherapeuticsIreland DAC: 1Janssen Research &Development, LLC: 1Janssen Research &Development, LLC: 1

Created with Highcharts 11.1.0Top CollaboratorsNational Institute ofAllergy and InfectiousDiseases (NIAID): 2National Institute ofAllergy and InfectiousDiseases (NIAID): 2Chiesi USA, Inc.: 1Chiesi USA, Inc.: 1International Networkfor Strategic Initiativesin Global HIV Trials(INSIGHT): 1International Networkfor Strategic Initiativesin Global HIV Trials(INSIGHT): 1National Institutes ofHealth (NIH): 1National Institutes ofHealth (NIH): 1

Clinical Trials Conditions at Infusion Associates


According to Clinical.Site data, the most researched conditions in "Infusion Associates" are "Fabry Disease" (8 trials), "Ulcerative Colitis" (2 trials), "Asthma" (1 trials), "COVID" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Infusion Associates" in a lesser frequency.

Clinical Trials Intervention Types at Infusion Associates


Most popular intervention types in "Infusion Associates" are "Drug" (13 trials), "Biological" (7 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Lucerastat" (2 trials), "Pegloticase" (2 trials), "pegunigalsidase alfa" (2 trials) and "AT2221" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Infusion Associates


The vast majority of trials in "Infusion Associates" are 18 trials for "All" genders.

Clinical Trials Status at Infusion Associates


Currently, there are NaN active trials in "Infusion Associates". undefined are not yet recruiting, 3 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Infusion Associates, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Infusion Associates, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 12Phase 3: 12Phase 2: 3Phase 2: 3Phase 1: 1Phase 1: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 7Active, not recruiting: 7Completed: 6Completed: 6Recruiting: 3Recruiting: 3Available: 1Available: 1No longer available: 1No longer available: 1